• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经桡动脉或股动脉入路行肝动脉化疗栓塞术时的术者辐射剂量:不同患者体位。

Operator radiation dose during trans-hepatic arterial chemoembolization: different patients' positions via transradial or transfemoral access.

机构信息

Department of Interventional Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.

Department of Radiology, Shanghai Jiaotong University, Shanghai Chest Hospital, Shanghai, China.

出版信息

Diagn Interv Radiol. 2022 Jul;28(4):376-382. doi: 10.5152/dir.2022.211327.

DOI:10.5152/dir.2022.211327
PMID:35950283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9634918/
Abstract

PURPOSE This study aimed to compare the radiation dose received by the operator among different patients' positions via transradial access (TRA) or transfemoral access (TFA) during transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). METHODS A total of 120 patients with HCC undergoing TACE for the first time between January and November 2019 were randomized into 4 groups with 30 patients in each group. In group A, patients were placed in the foot-first position with the left upper arm abducted, and TACE was performed via the left radial artery. In group B, patients were placed in the conventional headfirst position with the left hand placed at the left groin, and TACE was performed via the left radial artery. In group C, patients were placed in the conventional head-first position, and TACE was performed via the right radial artery. In group D, patients were placed in the conventional head-first position, and TACE was performed via the right femoral artery. Before each procedure, thermoluminescent dosimeters were taped at 7 different body parts of the operator and the radiation dose was measured and collected after the procedure. The normalized radiation dose was also calculated. Procedural parameters included radiation dose, fluoroscopy time (FT), dose-area product (DAP), and air kerma (AK) were recorded. Patients' demographics, tumor baseline characteristics, radiation dose, and procedural parameters were compared between groups. RESULTS No significant differences were found in patients' demographics, tumor baseline characteristics, as well as in total FT, DAP, and AK. However, significant differences were found in the total radiation dose received by the operator and the doses on the pelvic cavity and the right wrist (P < .05). In group C, the radiation doses received on the pelvic cavity, the right wrist, and the total radiation doses were relatively higher. Significant differences were also found in the normalized radiation doses received by the operator on the thyroid, chest, left wrist, right wrist, and pelvic cavity, and the total normalized doses (all P < .05). Similarly, the radiation doses received by the operator at the aforementioned parts in group C were higher, while those in group A were lower. CONCLUSION No statistically significant differences were observed in the FT, DAP, and AK in TACE via TRA when patients were placed in different positions. However, TACE via the left TRA, with patients in the feet-first position, reduced the radiation dose received by the operator, thereby reducing the radiation risk.

摘要

目的 本研究旨在比较经桡动脉入路(TRA)和经股动脉入路(TFA)行肝动脉化疗栓塞术(TACE)治疗肝细胞癌(HCC)时,不同患者体位下术者接受的辐射剂量。

方法 2019 年 1 月至 11 月期间,120 例首次接受 TACE 治疗的 HCC 患者被随机分为 4 组,每组 30 例。在 A 组中,患者取足先位,左上臂外展,经左侧桡动脉行 TACE。在 B 组中,患者取常规头先位,左手置于左腹股沟,经左侧桡动脉行 TACE。在 C 组中,患者取常规头先位,经右侧桡动脉行 TACE。在 D 组中,患者取常规头先位,经右侧股动脉行 TACE。在每次操作前,将热释光剂量计贴在术者身体的 7 个不同部位,并在操作后测量和收集辐射剂量。还计算了归一化辐射剂量。记录了手术过程中的参数,包括辐射剂量、透视时间(FT)、剂量面积乘积(DAP)和空气比释动能(AK)。比较了各组患者的一般资料、肿瘤基线特征、辐射剂量和手术过程参数。

结果 各组患者的一般资料、肿瘤基线特征、总 FT、DAP 和 AK 差异均无统计学意义。但术者总辐射剂量和盆腔、右腕部辐射剂量差异有统计学意义(P <.05)。在 C 组中,盆腔、右腕部和术者总辐射剂量相对较高。术者甲状腺、胸部、左腕部、右腕部和盆腔的归一化辐射剂量以及总归一化剂量差异也有统计学意义(均 P <.05)。同样,C 组术者上述部位接受的辐射剂量较高,而 A 组较低。

结论 经桡动脉入路行 TACE 时,患者体位不同,FT、DAP 和 AK 差异无统计学意义。然而,采用左 TRA,患者取足先位,可降低术者接受的辐射剂量,从而降低辐射风险。

相似文献

1
Operator radiation dose during trans-hepatic arterial chemoembolization: different patients' positions via transradial or transfemoral access.经桡动脉或股动脉入路行肝动脉化疗栓塞术时的术者辐射剂量:不同患者体位。
Diagn Interv Radiol. 2022 Jul;28(4):376-382. doi: 10.5152/dir.2022.211327.
2
Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.经桡动脉与经股动脉入路无封堵装置在原发性肝癌患者经动脉化疗栓塞术中的应用:一项随机试验。
Eur Radiol. 2022 Oct;32(10):6812-6819. doi: 10.1007/s00330-022-09038-1. Epub 2022 Aug 26.
3
Operator learning curve for transradial liver cancer embolization: implications for the initiation of a transradial access program.经桡动脉肝癌栓塞术的术者学习曲线:对经桡动脉入路项目开展的影响。
Diagn Interv Radiol. 2019 Sep;25(5):368-374. doi: 10.5152/dir.2019.18437.
4
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients.经桡动脉途径对肝细胞癌患者进行化疗栓塞术
J Vis Exp. 2020 Sep 20(163). doi: 10.3791/61109.
5
Transradial Access for Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: Comparison with Transfemoral Access.经桡动脉入路行经动脉放射性栓塞术(TARE)治疗肝细胞癌:与经股动脉入路的比较。
Cardiovasc Intervent Radiol. 2023 Oct;46(10):1359-1364. doi: 10.1007/s00270-023-03542-7. Epub 2023 Sep 18.
6
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study.经桡动脉与经股动脉途径在肝动脉化疗栓塞中的应用:患者自身对照前瞻性单中心研究
J Vasc Interv Radiol. 2017 Sep;28(9):1234-1239. doi: 10.1016/j.jvir.2017.06.022. Epub 2017 Jul 27.
7
Radiation exposure during TACE procedures using additional cone-beam CT (CBCT) for guidance: safety and precautions.在使用附加锥形束CT(CBCT)进行引导的经动脉化疗栓塞(TACE)手术过程中的辐射暴露:安全性及注意事项。
Acta Radiol. 2018 Nov;59(11):1277-1284. doi: 10.1177/0284185118761203. Epub 2018 Feb 28.
8
Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access.经桡动脉途径与经股动脉途径化疗栓塞治疗肝细胞癌的比较
Transl Cancer Res. 2019 Sep;8(5):1795-1805. doi: 10.21037/tcr.2019.08.40.
9
Occupational dose and associated factors during transarterial chemoembolization of hepatocellular carcinoma using real-time dosimetry: A simple way to reduce radiation exposure.实时剂量测定在经导管肝动脉化疗栓塞术治疗肝细胞癌中的职业剂量及相关因素:降低辐射暴露的简单方法。
Medicine (Baltimore). 2022 Jan 28;101(4):e28744. doi: 10.1097/MD.0000000000028744.
10
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Satisfaction.肝癌栓塞中经桡动脉与经股动脉入路:评估患者满意度的随机试验
J Vasc Interv Radiol. 2018 Jan;29(1):38-43. doi: 10.1016/j.jvir.2017.08.024. Epub 2017 Nov 15.

引用本文的文献

1
Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization.术前纤维蛋白原、中性粒细胞与淋巴细胞比值、血清甲胎蛋白及前白蛋白对接受经动脉化疗栓塞术的原发性肝癌患者的预后价值
World J Gastrointest Oncol. 2025 Jun 15;17(6):103198. doi: 10.4251/wjgo.v17.i6.103198.
2
Left radial vs right femoral: comparison between arterial accesses in c-TACE procedures in terms of operator radiations exposure and patient comfort.左桡动脉与右股动脉:在经动脉化疗栓塞(c-TACE)手术中,就术者辐射暴露和患者舒适度而言,两种动脉入路的比较
Radiol Med. 2024 Dec;129(12):1936-1943. doi: 10.1007/s11547-024-01906-8. Epub 2024 Nov 4.
3
Chinese expert consensus on transradial access in percutaneous peripheral interventions.经桡动脉途径在经皮外周介入治疗中的中国专家共识
J Interv Med. 2023 Nov 10;6(4):145-152. doi: 10.1016/j.jimed.2023.10.005. eCollection 2023 Nov.
4
The clinical application of transarterial embolization via radial artery in hemorrhagic diseases in obstetrics and gynecology.经桡动脉行子宫动脉栓塞术在妇产科出血性疾病中的临床应用
Front Med (Lausanne). 2023 Oct 19;10:1273179. doi: 10.3389/fmed.2023.1273179. eCollection 2023.
5
Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma.肝细胞癌局部区域治疗的最新进展
Cancers (Basel). 2023 Jun 26;15(13):3347. doi: 10.3390/cancers15133347.

本文引用的文献

1
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
2
Prospective Study on Total Fluoroscopic Time in Patients Undergoing Uterine Artery Embolization: Comparing Transradial and Transfemoral Approaches.子宫动脉栓塞术患者总透视时间的前瞻性研究:经桡动脉与经股动脉途径比较
Cardiovasc Intervent Radiol. 2019 Mar;42(3):441-447. doi: 10.1007/s00270-018-2100-3. Epub 2018 Oct 29.
3
A reality check in transradial access: a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention.经桡动脉入路的现实情况检查:经桡动脉与经股动脉入路用于腹部和外周介入的单中心比较。
Eur Radiol. 2019 Jan;29(1):68-74. doi: 10.1007/s00330-018-5580-2. Epub 2018 Jun 20.
4
Operator Pelvic Radiation Exposure During Percutaneous Coronary Procedures.经皮冠状动脉介入手术期间术者的盆腔辐射暴露
J Invasive Cardiol. 2018 Feb;30(2):71-74. Epub 2017 Dec 15.
5
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Satisfaction.肝癌栓塞中经桡动脉与经股动脉入路:评估患者满意度的随机试验
J Vasc Interv Radiol. 2018 Jan;29(1):38-43. doi: 10.1016/j.jvir.2017.08.024. Epub 2017 Nov 15.
6
Determinants of operator radiation exposure during percutaneous coronary procedures.经皮冠状动脉介入手术中术者辐射暴露的决定因素。
Am Heart J. 2017 May;187:10-18. doi: 10.1016/j.ahj.2017.02.012. Epub 2017 Feb 17.
7
Prostate Artery Embolization via Transradial or Transulnar versus Transfemoral Arterial Access: Technical Results.经桡动脉或尺动脉与经股动脉途径进行前列腺动脉栓塞术:技术结果
J Vasc Interv Radiol. 2017 Jun;28(6):898-905. doi: 10.1016/j.jvir.2017.02.029. Epub 2017 Apr 7.
8
Transradial Approach for Hepatic Radioembolization: Initial Results and Technique.经桡动脉入路肝动脉放射性栓塞术:初始结果和技术。
AJR Am J Roentgenol. 2016 Nov;207(5):1112-1121. doi: 10.2214/AJR.15.15615.
9
Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access.经桡动脉途径进行肝动脉放射性栓塞:初步经验及与经股动脉途径的比较。
Diagn Interv Radiol. 2016 Sep-Oct;22(5):444-9. doi: 10.5152/dir.2016.15571.
10
Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.经桡动脉化疗栓塞术可降低肝细胞癌患者的并发症发生率及治疗费用。
Indian J Cancer. 2015 Dec;52 Suppl 2:e107-11. doi: 10.4103/0019-509X.172505.